Camurus Ab Stock Market Value
| CAMRF Stock | USD 71.00 0.00 0.00% |
| Symbol | Camurus |
Camurus AB 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Camurus AB's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Camurus AB.
| 10/31/2025 |
| 01/29/2026 |
If you would invest 0.00 in Camurus AB on October 31, 2025 and sell it all today you would earn a total of 0.00 from holding Camurus AB or generate 0.0% return on investment in Camurus AB over 90 days. Camurus AB is related to or competes with Laboratorios Farmaceuticos, Genscript Biotech, ALK Abell, Ambu A/S, InnoCare Pharma, Shanghai Junshi, and Telix Pharmaceuticals. Camurus AB , a pharmaceutical company, develops and commercializes medicines for severe and chronic conditions in Europe... More
Camurus AB Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Camurus AB's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Camurus AB upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.0063 | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (0.04) |
Camurus AB Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Camurus AB's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Camurus AB's standard deviation. In reality, there are many statistical measures that can use Camurus AB historical prices to predict the future Camurus AB's volatility.| Risk Adjusted Performance | 0.0301 | |||
| Jensen Alpha | 0.0709 | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | 0.4031 |
Camurus AB January 29, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0301 | |||
| Market Risk Adjusted Performance | 0.4131 | |||
| Mean Deviation | 0.876 | |||
| Coefficient Of Variation | 3272.25 | |||
| Standard Deviation | 3.09 | |||
| Variance | 9.56 | |||
| Information Ratio | 0.0063 | |||
| Jensen Alpha | 0.0709 | |||
| Total Risk Alpha | (0.19) | |||
| Treynor Ratio | 0.4031 | |||
| Maximum Drawdown | 18.53 | |||
| Value At Risk | (0.04) | |||
| Skewness | (0.37) | |||
| Kurtosis | 20.99 |
Camurus AB Backtested Returns
At this point, Camurus AB is very steady. Camurus AB secures Sharpe Ratio (or Efficiency) of 0.0315, which signifies that the company had a 0.0315 % return per unit of risk over the last 3 months. We have found eighteen technical indicators for Camurus AB, which you can use to evaluate the volatility of the firm. Please confirm Camurus AB's Mean Deviation of 0.876, risk adjusted performance of 0.0301, and Standard Deviation of 3.09 to double-check if the risk estimate we provide is consistent with the expected return of 0.1%. Camurus AB has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.21, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Camurus AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding Camurus AB is expected to be smaller as well. Camurus AB right now shows a risk of 3.19%. Please confirm Camurus AB standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and rate of daily change , to decide if Camurus AB will be following its price patterns.
Auto-correlation | -0.11 |
Insignificant reverse predictability
Camurus AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Camurus AB time series from 31st of October 2025 to 15th of December 2025 and 15th of December 2025 to 29th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Camurus AB price movement. The serial correlation of -0.11 indicates that less than 11.0% of current Camurus AB price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.11 | |
| Spearman Rank Test | -0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 7.51 |
Currently Active Assets on Macroaxis
Other Information on Investing in Camurus OTC Stock
Camurus AB financial ratios help investors to determine whether Camurus OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Camurus with respect to the benefits of owning Camurus AB security.